{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T02:57:39Z","timestamp":1780973859706,"version":"3.54.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Taikang Healthcare Young Medical Research Fund","award":["2024021"],"award-info":[{"award-number":["2024021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-02061-0","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:15:59Z","timestamp":1777083359000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between amyloid-\u03b2 deposition and cognitive function in cognitively normal adults: a multilevel meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"given":"Yanlu","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"issue":"8","key":"2061_CR1","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack","year":"2024","unstructured":"Jack CR, Andrews JS, Beach TG, et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 2024;20(8):5143\u201369.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2061_CR2","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"CR Jack Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimers Dement. 2018;14(4):535\u201362.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"2061_CR3","doi-asserted-by":"publisher","first-page":"e70017","DOI":"10.1002\/hup.70017","volume":"40","author":"Y Wei","year":"2025","unstructured":"Wei Y, Li H. The Efficacy and Safety of Amyloid Beta-Directed Monoclonal Antibodies for Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis of Phase III Randomized Controlled Trials. Hum Psychopharmacol. 2025;40(5):e70017.","journal-title":"Hum Psychopharmacol"},{"key":"2061_CR4","doi-asserted-by":"crossref","unstructured":"Alkhalifa AE, Mokhlf AA, Ali H, Al-Ghraiybah NF, Syropoulou V. Anti-Amyloid Monoclonal Antibodies for Alzheimer\u2019s Disease: Evidence, ARIA Risk, and Precision Patient Selection. J Pers Med. 2025;15(9):437.","DOI":"10.3390\/jpm15090437"},{"issue":"22","key":"2061_CR5","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1001\/jama.2017.6669","volume":"317","author":"MC Donohue","year":"2017","unstructured":"Donohue MC, Sperling RA, Petersen R, et al. Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons. JAMA. 2017;317(22):2305\u201316.","journal-title":"JAMA"},{"issue":"2","key":"2061_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/acn3.51273","volume":"8","author":"W Pelkmans","year":"2021","unstructured":"Pelkmans W, Legdeur N, Ten Kate M, et al. Amyloid-\u03b2, cortical thickness, and subsequent cognitive decline in cognitively normal oldest-old. Ann Clin Transl Neurol. 2021;8(2):348\u201358.","journal-title":"Ann Clin Transl Neurol"},{"issue":"17","key":"2061_CR7","doi-asserted-by":"publisher","first-page":"e1452","DOI":"10.1212\/WNL.0000000000005354","volume":"90","author":"SM Landau","year":"2018","unstructured":"Landau SM, Horng A, Jagust WJ. Alzheimer\u2019s Disease Neuroimaging Initiative. Memory decline accompanies subthreshold amyloid accumulation. Neurology. 2018;90(17):e1452\u201360.","journal-title":"Neurology"},{"issue":"14","key":"2061_CR8","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1212\/WNL.0b013e31828ab35d","volume":"80","author":"T Hedden","year":"2013","unstructured":"Hedden T, Oh H, Younger AP, Patel TA. Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology. 2013;80(14):1341\u20138.","journal-title":"Neurology"},{"key":"2061_CR9","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.dadm.2016.09.002","volume":"6","author":"JE Baker","year":"2017","unstructured":"Baker JE, Lim YY, Pietrzak RH, et al. Cognitive impairment and decline in cognitively normal older adults with high amyloid-\u03b2: A meta-analysis. Alzheimers Dement (Amst). 2017;6:108\u201321.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"S4","key":"2061_CR10","doi-asserted-by":"publisher","first-page":"e057478","DOI":"10.1002\/alz.057478","volume":"17","author":"C Ferreira-Atuesta","year":"2021","unstructured":"Ferreira-Atuesta C, Piendel LA, Emerson JM, Joshi N, Hedden T. Meta-analysis of the associations of biomarkers of amyloid and tau with cognition in cognitively normal older adults. Alzheimer\u2019s Dement. 2021;17(S4):e057478.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2061_CR11","doi-asserted-by":"publisher","first-page":"100074","DOI":"10.1016\/j.nbas.2023.100074","volume":"3","author":"C Parent","year":"2023","unstructured":"Parent C, Rousseau LS, Predovan D, Duchesne S, Hudon C. Longitudinal association between \u00df-amyloid accumulation and cognitive decline in cognitively healthy older adults: A systematic review. Aging Brain. 2023;3:100074.","journal-title":"Aging Brain"},{"key":"2061_CR12","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"Pt 11","key":"2061_CR13","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1093\/brain\/awm238","volume":"130","author":"KE Pike","year":"2007","unstructured":"Pike KE, Savage G, Villemagne VL, et al. Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer\u2019s disease. Brain. 2007;130(Pt 11):2837\u201344.","journal-title":"Brain"},{"issue":"11","key":"2061_CR14","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1001\/archneur.65.11.1509","volume":"65","author":"HJ Aizenstein","year":"2008","unstructured":"Aizenstein HJ, Nebes RD, Saxton JA, et al. Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch Neurol. 2008;65(11):1509\u201317.","journal-title":"Arch Neurol"},{"issue":"10","key":"2061_CR15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1212\/WNL.0b013e3181d3e3e9","volume":"74","author":"SM Resnick","year":"2010","unstructured":"Resnick SM, Sojkova J, Zhou Y, et al. Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11\u00a0C]PiB. Neurology. 2010;74(10):807\u201315.","journal-title":"Neurology"},{"issue":"9","key":"2061_CR16","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1016\/j.neuropsychologia.2011.06.006","volume":"49","author":"DM Rentz","year":"2011","unstructured":"Rentz DM, Amariglio RE, Becker JA, et al. Face-name associative memory performance is related to amyloid burden in normal elderly. Neuropsychologia. 2011;49(9):2776\u201383.","journal-title":"Neuropsychologia"},{"issue":"2","key":"2061_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1001\/archneurol.2011.666","volume":"69","author":"A Perrotin","year":"2012","unstructured":"Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ. Subjective cognition and amyloid deposition imaging a pittsburgh compound B positron emission tomography study in normal elderly individuals. Arch Neurol. 2012;69(2):223\u20139.","journal-title":"Arch Neurol"},{"issue":"6","key":"2061_CR18","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1212\/WNL.0b013e318245d295","volume":"78","author":"KM Rodrigue","year":"2012","unstructured":"Rodrigue KM, Kennedy KM, Devous Sr MD, et al. \u03b2-amyloid burden in healthy aging: Regional distribution and cognitive consequences. NEUROLOGY. 2012;78(6):387\u201395.","journal-title":"NEUROLOGY"},{"issue":"5","key":"2061_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jalz.2012.07.004","volume":"9","author":"YY Lim","year":"2013","unstructured":"Lim YY, Ellis KA, Ames D, et al. A\u03b2 amyloid, cognition, and APOE genotype in healthy older adults. Alzheimer\u2019s Dement. 2013;9(5):538\u201345.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2061_CR20","doi-asserted-by":"crossref","unstructured":"Rosenberg PB, Wong DF, Edell SL, et al. Cognition and amyloid load in alzheimer disease imaged with florbetapir F 18(AV-45) positron emission tomography. Am J Geriatr Psychiatry. 2013;21(3):272\u20138.","DOI":"10.1016\/j.jagp.2012.11.016"},{"issue":"6","key":"2061_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jalz.2012.10.012","volume":"9","author":"M Wirth","year":"2013","unstructured":"Wirth M, Oh H, Mormino EC, Markley C, Landau SM, Jagust WJ. The effect of amyloid \u03b2 on cognitive decline is modulated by neural integrity in cognitively normal elderly. Alzheimers Dement. 2013;9(6):687\u2013e6981.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2061_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.3233\/JAD-140678","volume":"43","author":"S Hollands","year":"2015","unstructured":"Hollands S, Lim YY, Buckley R, et al. Amyloid-beta related memory decline is not associated with subjective or informant rated cognitive impairment in healthy adults. J Alzheimers Dis. 2015;43(2):677\u201386.","journal-title":"J Alzheimers Dis"},{"issue":"17","key":"2061_CR23","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1212\/WNL.0000000000002604","volume":"86","author":"YY Lim","year":"2016","unstructured":"Lim YY, Laws SM, Villemagne VL, et al. A\u03b2-related memory decline in APOE \u03b54 noncarriers: Implications for Alzheimer disease. Neurology. 2016;86(17):1635\u201342.","journal-title":"Neurology"},{"issue":"5","key":"2061_CR24","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1037\/neu0000246","volume":"30","author":"KV Papp","year":"2016","unstructured":"Papp KV, Mormino EC, Amariglio RE, et al. Biomarker validation of a decline in semantic processing in preclinical Alzheimer\u2019s disease. Neuropsychology. 2016;30(5):624\u201330.","journal-title":"Neuropsychology"},{"issue":"1","key":"2061_CR25","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1001\/jamaneurol.2015.3098","volume":"73","author":"RC Petersen","year":"2016","unstructured":"Petersen RC, Wiste HJ, Weigand SD, et al. Association of Elevated Amyloid Levels With Cognition and Biomarkers in Cognitively Normal People From the Community. JAMA Neurol. 2016;73(1):85\u201392.","journal-title":"JAMA Neurol"},{"issue":"7","key":"2061_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1001\/jamaneurol.2017.0892","volume":"74","author":"ME Farrell","year":"2017","unstructured":"Farrell ME, Kennedy KM, Rodrigue KM, et al. Association of Longitudinal Cognitive Decline With Amyloid Burden in Middle-aged and Older Adults: Evidence for a Dose-Response Relationship. JAMA Neurol. 2017;74(7):830\u20138.","journal-title":"JAMA Neurol"},{"issue":"9","key":"2061_CR27","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jalz.2017.01.018","volume":"13","author":"EC Mormino","year":"2017","unstructured":"Mormino EC, Papp KV, Rentz DM, et al. Early and late change on the preclinical Alzheimer\u2019s cognitive composite in clinically normal older individuals with elevated amyloid \u03b2. Alzheimers Dement. 2017;13(9):1004\u201312.","journal-title":"Alzheimers Dement"},{"issue":"15","key":"2061_CR28","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1212\/WNL.0000000000003812","volume":"88","author":"KV Papp","year":"2017","unstructured":"Papp KV, Rentz DM, Mormino EC, et al. Cued memory decline in biomarker-defined preclinical Alzheimer disease. Neurology. 2017;88(15):1431\u20138.","journal-title":"Neurology"},{"issue":"1","key":"2061_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1037\/pag0000217","volume":"33","author":"MM Horn","year":"2018","unstructured":"Horn MM, Kennedy KM, Rodrigue KM. Association between subjective memory assessment and associative memory performance: Role of ad risk factors. Psychol Aging. 2018;33(1):109\u201318.","journal-title":"Psychol Aging"},{"issue":"3","key":"2061_CR30","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1212\/WNL.0000000000004827","volume":"90","author":"N Kemppainen","year":"2018","unstructured":"Kemppainen N, Johansson J, Teuho J, et al. Brain amyloid load and its associations with cognition and vascular risk factors in FINGER Study. Neurology. 2018;90(3):e206\u201313.","journal-title":"Neurology"},{"issue":"1","key":"2061_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11682-016-9668-5","volume":"12","author":"GE McCluskey","year":"2018","unstructured":"McCluskey GE, Yates P, Villemagne VL, Rowe C, Szoeke C. Self-reported confusion is related to global and regional \u03b2-amyloid: data from the Women\u2019s healthy ageing project. Brain Imaging Behav. 2018;12(1):78\u201386.","journal-title":"Brain Imaging Behav"},{"key":"2061_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.dadm.2017.11.003","volume":"10","author":"I Orlovsky","year":"2018","unstructured":"Orlovsky I, Huijbers W, Hanseeuw BJ, et al. The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults. Alzheimers Dement (Amst). 2018;10:121\u20139.","journal-title":"Alzheimers Dement (Amst)"},{"issue":"2","key":"2061_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"RA Sperling","year":"2019","unstructured":"Sperling RA, Mormino EC, Schultz AP, et al. The impact of amyloid-beta and tau on prospective cognitive decline in older individuals. Ann Neurol. 2019;85(2):181\u201393.","journal-title":"Ann Neurol"},{"key":"2061_CR34","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.neurobiolaging.2019.02.020","volume":"79","author":"T Timmers","year":"2019","unstructured":"Timmers T, Ossenkoppele R, Verfaillie S, et al. Amyloid PET and cognitive decline in cognitively normal individuals: the SCIENCe project. Neurobiol Aging. 2019;79:50\u20138.","journal-title":"Neurobiol Aging"},{"issue":"14","key":"2061_CR35","doi-asserted-by":"publisher","first-page":"e1512","DOI":"10.1212\/WNL.0000000000009216","volume":"94","author":"T Guo","year":"2020","unstructured":"Guo T, Landau SM, Jagust WJ. Detecting earlier stages of amyloid deposition using PET in cognitively normal elderly adults. NEUROLOGY. 2020;94(14):e1512\u201324.","journal-title":"NEUROLOGY"},{"issue":"1","key":"2061_CR36","doi-asserted-by":"publisher","first-page":"16665","DOI":"10.1038\/s41598-020-73673-1","volume":"10","author":"S Haller","year":"2020","unstructured":"Haller S, Montandon ML, Lilja J, et al. PET amyloid in normal aging: direct comparison of visual and automatic processing methods. Sci Rep. 2020;10(1):16665.","journal-title":"Sci Rep"},{"issue":"5","key":"2061_CR37","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/acn3.51048","volume":"7","author":"PS Insel","year":"2020","unstructured":"Insel PS, Donohue MC, Sperling R, Hansson O, Mattsson-Carlgren N. The A4 study: \u03b2-amyloid and cognition in 4432 cognitively unimpaired adults. Ann Clin Transl Neurol. 2020;7(5):776\u201385.","journal-title":"Ann Clin Transl Neurol"},{"issue":"8","key":"2061_CR38","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1037\/neu0000696","volume":"34","author":"CA Lindbergh","year":"2020","unstructured":"Lindbergh CA, Casaletto KB, Staffaroni AM, et al. Sex-related differences in the relationship between \u03b2-amyloid and cognitive trajectories in older adults. Neuropsychology. 2020;34(8):835\u201350.","journal-title":"Neuropsychology"},{"key":"2061_CR39","doi-asserted-by":"crossref","unstructured":"Samaroo A, Amariglio RE, Burnham S, et al. Diminished learning over repeated exposures (LORE) in preclinical alzheimer\u2019s disease. Alzheimers Dement (Amst). 2020;12(1):e12132.","DOI":"10.1002\/dad2.12132"},{"issue":"6","key":"2061_CR40","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","volume":"77","author":"RA Sperling","year":"2020","unstructured":"Sperling RA, Donohue MC, Raman R, et al. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals. JAMA Neurol. 2020;77(6):735\u201345.","journal-title":"JAMA Neurol"},{"key":"2061_CR41","doi-asserted-by":"publisher","first-page":"117199","DOI":"10.1016\/j.neuroimage.2020.117199","volume":"221","author":"CE Webb","year":"2020","unstructured":"Webb CE, Foster CM, Horn MM, Kennedy KM, Rodrigue KM. Beta-amyloid burden predicts poorer mnemonic discrimination in cognitively normal older adults. NeuroImage. 2020;221:117199.","journal-title":"NeuroImage"},{"issue":"1","key":"2061_CR42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3233\/JAD-200526","volume":"78","author":"R Zhang","year":"2020","unstructured":"Zhang R, Chen S, Shen X, et al. Elevated tau PET signal depends on abnormal amyloid levels and correlates with cognitive impairment in elderly persons without dementia. J Alzheimers Dis. 2020;78(1):395\u2013404.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"2061_CR43","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/alz.12249","volume":"17","author":"TM Harrison","year":"2021","unstructured":"Harrison TM, Du R, Klencklen G, Baker SL, Jagust WJ. Distinct effects of beta-amyloid and tau on cortical thickness in cognitively healthy older adults. Alzheimers Dement. 2021;17(7):1085\u201396.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2061_CR44","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13195-021-00918-0","volume":"13","author":"F Levin","year":"2021","unstructured":"Levin F, Jelistratova I, Betthauser TJ, et al. In vivo staging of regional amyloid progression in healthy middle-aged to older people at risk of Alzheimer\u2019s disease. Alzheimers Res Ther. 2021;13(1):178.","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"2061_CR45","doi-asserted-by":"publisher","first-page":"8527","DOI":"10.1002\/alz.14290","volume":"20","author":"S Chaudhuri","year":"2024","unstructured":"Chaudhuri S, Dempsey DA, Huang YN, et al. Association of amyloid and cardiovascular risk with cognition: Findings from KBASE. Alzheimers Dement. 2024;20(12):8527\u201340.","journal-title":"Alzheimers Dement"},{"issue":"12","key":"2061_CR46","doi-asserted-by":"publisher","first-page":"8728","DOI":"10.1002\/alz.14326","volume":"20","author":"HM Klinger","year":"2024","unstructured":"Klinger HM, Healy BC, Hanseeuw BJ, et al. Latent change-on\u2010change between amyloid accumulation and cognitive decline. Alzheimer\u2019s Dement. 2024;20(12):8728\u201338.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"3","key":"2061_CR47","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1002\/ana.26833","volume":"95","author":"KV Papp","year":"2024","unstructured":"Papp KV, Jutten RJ, Soberanes D, et al. Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital Testing. Ann Neurol. 2024;95(3):507\u201317.","journal-title":"Ann Neurol"},{"issue":"1","key":"2061_CR48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13195-024-01494-9","volume":"16","author":"L Quenon","year":"2024","unstructured":"Quenon L, Collij LE, Garcia DV, et al. Amyloid-PET imaging predicts functional decline in clinically normal individuals. Alzheimers Res Ther. 2024;16(1):130.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"2061_CR49","doi-asserted-by":"publisher","first-page":"802","DOI":"10.14283\/jpad.2024.122","volume":"11","author":"RA Sperling","year":"2024","unstructured":"Sperling RA, Donohue MC, Rissman RA, et al. Amyloid and tau prediction of cognitive and functional decline in unimpaired older individuals: Longitudinal data from the A4 and LEARN studies. J Prev Alzheimer\u2019s Disease. 2024;11(4):802\u201313.","journal-title":"J Prev Alzheimer\u2019s Disease"},{"key":"2061_CR50","doi-asserted-by":"publisher","unstructured":"Vanderlip CR, Taylor L, Kim S et al. Amyloid-\u03b2 deposition in basal frontotemporal cortex is associated with selective disruption of temporal mnemonic discrimination. bioRxiv [Preprint Server for Biology]. 2024. https:\/\/doi.org\/10.1101\/2024.08.23.609449.","DOI":"10.1101\/2024.08.23.609449"},{"issue":"4","key":"2061_CR51","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/brain\/awae316","volume":"148","author":"K Lu","year":"2025","unstructured":"Lu K, Baker J, Nicholas JM, et al. Associations between accelerated forgetting, amyloid deposition and brain atrophy in older adults. Brain. 2025;148(4):1302\u201315.","journal-title":"Brain"},{"key":"2061_CR52","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neuropsychologia.2015.09.024","volume":"78","author":"C Pettigrew","year":"2015","unstructured":"Pettigrew C, Soldan A, Moghekar A, et al. Relationship between cerebrospinal fluid biomarkers of alzheimer\u2019s disease and cognition in cognitively normal older adults. Neuropsychologia. 2015;78:63\u201372.","journal-title":"Neuropsychologia"},{"issue":"15","key":"2061_CR53","doi-asserted-by":"publisher","first-page":"E1306","DOI":"10.1212\/WNL.0000000000005291","volume":"90","author":"LR Clark","year":"2018","unstructured":"Clark LR, Berman SE, Norton D, et al. Age-accelerated cognitive decline in asymptomatic adults with CSF \u03b2-amyloid. NEUROLOGY. 2018;90(15):E1306\u201315.","journal-title":"NEUROLOGY"},{"issue":"14","key":"2061_CR54","doi-asserted-by":"publisher","first-page":"e1567","DOI":"10.1212\/WNL.0000000000007248","volume":"92","author":"A Soldan","year":"2019","unstructured":"Soldan A, Pettigrew C, Fagan AM, et al. ATN profiles among cognitively normal individuals and longitudinal cognitive outcomes. Neurology. 2019;92(14):e1567\u201379.","journal-title":"Neurology"},{"issue":"10","key":"2061_CR55","doi-asserted-by":"publisher","first-page":"e1470","DOI":"10.1212\/WNL.0000000000011477","volume":"96","author":"AN Trelle","year":"2021","unstructured":"Trelle AN, Carr VA, Wilson EN, et al. Association of CSF Biomarkers With Hippocampal-Dependent Memory in Preclinical Alzheimer Disease. NEUROLOGY. 2021;96(10):e1470\u201381.","journal-title":"NEUROLOGY"},{"issue":"11","key":"2061_CR56","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1002\/acn3.52209","volume":"11","author":"CJ Bolton","year":"2024","unstructured":"Bolton CJ, Khan OA, Liu D, et al. Cognitive status and demographics modify the association between subjective cognition and amyloid. Ann Clin Transl Neurol. 2024;11(11):2977\u201386.","journal-title":"Ann Clin Transl Neurol"},{"key":"2061_CR57","doi-asserted-by":"crossref","unstructured":"Levine TF, Dessenberger SJ, Allison SL, Head D, Alzheimers Dis N. Alzheimer disease biomarkers are associated with decline in subjective memory, attention, and spatial navigation ability in clinically normal adults. J Int Neuropsychol Soc. 2024;30(4):313\u201327.","DOI":"10.1017\/S135561772300070X"},{"issue":"2","key":"2061_CR58","doi-asserted-by":"publisher","first-page":"e14415","DOI":"10.1002\/alz.14415","volume":"21","author":"R Cacciaglia","year":"2025","unstructured":"Cacciaglia R, Falc\u00f3n C, Benavides GS, et al. Soluble a\u03b2 pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest alzheimer\u2019s continuum: Evidence across two independent cohorts. Alzheimer\u2019s Dement. 2025;21(2):e14415.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"5\u20136","key":"2061_CR59","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1080\/10284150701676156","volume":"10","author":"TM Leahey","year":"2007","unstructured":"Leahey TM, Myers TA, Gunstad J, et al. Abeta40 is associated with cognitive function, body fat and physical fitness in healthy older adults. Nutr Neurosci. 2007;10(5\u20136):205\u20139.","journal-title":"Nutr Neurosci"},{"issue":"3","key":"2061_CR60","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1176\/jnp.2008.20.3.327","volume":"20","author":"J Gunstad","year":"2008","unstructured":"Gunstad J, Spitznagel MB, Glickman E, et al. beta-Amyloid is associated with reduced cognitive function in healthy older adults. J Neuropsychiatry Clin Neurosci. 2008;20(3):327\u201330.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"10","key":"2061_CR61","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1001\/archneurol.2009.207","volume":"66","author":"OI Okereke","year":"2009","unstructured":"Okereke OI, Xia W, Selkoe DJ, Grodstein F. Ten-year change in plasma amyloid beta levels and late-life cognitive decline. Arch Neurol. 2009;66(10):1247\u201353.","journal-title":"Arch Neurol"},{"issue":"3","key":"2061_CR62","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jama.2010.1995","volume":"305","author":"K Yaffe","year":"2011","unstructured":"Yaffe K, Weston A, Graff-Radford NR, et al. Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline. JAMA. 2011;305(3):261\u20136.","journal-title":"JAMA"},{"issue":"10","key":"2061_CR63","doi-asserted-by":"publisher","first-page":"2791","DOI":"10.1016\/j.neurobiolaging.2015.06.023","volume":"36","author":"S Llado-Saz","year":"2015","unstructured":"Llado-Saz S, Atienza M, Cantero JL. Increased levels of plasma amyloid-beta are related to cortical thinning and cognitive decline in cognitively normal elderly subjects. Neurobiol Aging. 2015;36(10):2791\u20137.","journal-title":"Neurobiol Aging"},{"key":"2061_CR64","doi-asserted-by":"publisher","first-page":"555","DOI":"10.2147\/CIA.S357994","volume":"17","author":"J Wang","year":"2022","unstructured":"Wang J, Gao L, Liu J, et al. The association of plasma amyloid-\u03b2 and cognitive decline in cognitively unimpaired population. Clin Interv Aging. 2022;17:555\u201365.","journal-title":"Clin Interv Aging"},{"issue":"S14","key":"2061_CR65","doi-asserted-by":"publisher","first-page":"e078964","DOI":"10.1002\/alz.078964","volume":"19","author":"LMC Lorenz","year":"2023","unstructured":"Lorenz LMC, Zhang M, Tesi N, et al. The association between levels of plasma biomarkers and cognitive performance in the oldest old. Alzheimer\u2019s Dement. 2023;19(S14):e078964.","journal-title":"Alzheimer\u2019s Dement"},{"key":"2061_CR66","doi-asserted-by":"crossref","unstructured":"Dark HE, An Y, Duggan MR et al. Alzheimer\u2019s and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline. Alzheimers Res Therapy. 2024;16(1):94.","DOI":"10.1186\/s13195-024-01459-y"},{"issue":"3","key":"2061_CR67","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3233\/JAD-230976","volume":"97","author":"M Schwinne","year":"2024","unstructured":"Schwinne M, Alonso A, Roberts BR, et al. The association of alzheimer\u2019s disease-related blood-based biomarkers with cognitive screening test performance in the congolese population in kinshasa. J Alzheimers Dis. 2024;97(3):1353\u201363.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"2061_CR68","doi-asserted-by":"publisher","first-page":"e14619","DOI":"10.1002\/alz.14619","volume":"21","author":"KR Sewell","year":"2025","unstructured":"Sewell KR, Oberlin LE, Karikari TK, et al. Blood biomarkers differentiate AD-related versus non\u2010AD\u2010related cognitive deficits. Alzheimer\u2019s Dement. 2025;21(3):e14619.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"2","key":"2061_CR69","doi-asserted-by":"publisher","first-page":"e14442","DOI":"10.1002\/alz.14442","volume":"21","author":"AN Trelle","year":"2025","unstructured":"Trelle AN, Young CB, Vossler H, et al. Plasma A\u03b242\/A\u03b240 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the alzheimer\u2019s disease spectrum. Alzheimer\u2019s Dement. 2025;21(2):e14442.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"19","key":"2061_CR70","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1212\/WNL.0b013e3182918ca6","volume":"80","author":"CM Roe","year":"2013","unstructured":"Roe CM, Fagan AM, Grant EA, et al. Amyloid imaging and CSF biomarkers in predicting cognitive impairment up to 7.5 years later. Neurology. 2013;80(19):1784\u201391.","journal-title":"Neurology"},{"issue":"4","key":"2061_CR71","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.3233\/JAD-170511","volume":"60","author":"J Dumurgier","year":"2017","unstructured":"Dumurgier J, Hanseeuw BJ, Hatling FB, et al. Alzheimer\u2019s disease biomarkers and future decline in cognitive normal older adults. J Alzheimers Dis. 2017;60(4):1451\u20139.","journal-title":"J Alzheimers Dis"},{"issue":"15","key":"2061_CR72","doi-asserted-by":"publisher","first-page":"E1525","DOI":"10.1212\/WNL.0000000000013299","volume":"98","author":"P Tideman","year":"2022","unstructured":"Tideman P, Stomrud E, Leuzy A, Mattsson-Carlgren N, Palmqvist S, Hansson O. Association of \u03b2-amyloid accumulation with executive function in adults with unimpaired cognition. NEUROLOGY. 2022;98(15):E1525\u201333.","journal-title":"NEUROLOGY"},{"issue":"3","key":"2061_CR73","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7(3):280\u201392.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"2061_CR74","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, Pichet Binette A, Groot C, et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat Med. 2022;28(11):2381\u20137.","journal-title":"Nat Med"},{"issue":"21","key":"2061_CR75","doi-asserted-by":"publisher","first-page":"e2185","DOI":"10.1212\/WNL.0000000000207844","volume":"101","author":"M Stark","year":"2023","unstructured":"Stark M, Wolfsgruber S, Kleineidam L, et al. Relevance of Minor Neuropsychological Deficits in Patients With Subjective Cognitive Decline. Neurology. 2023;101(21):e2185\u201396.","journal-title":"Neurology"},{"issue":"14","key":"2061_CR76","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1212\/WNL.0000000000001991","volume":"85","author":"S Palmqvist","year":"2015","unstructured":"Palmqvist S, Zetterberg H, Mattsson N, et al. Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease. Neurology. 2015;85(14):1240\u20139.","journal-title":"Neurology"},{"issue":"4","key":"2061_CR77","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1093\/brain\/awaa068","volume":"143","author":"D Berron","year":"2020","unstructured":"Berron D, van Westen D, Ossenkoppele R, Strandberg O, Hansson O. Medial temporal lobe connectivity and its associations with cognition in early Alzheimer\u2019s disease. Brain. 2020;143(4):1233\u201348.","journal-title":"Brain"},{"issue":"12","key":"2061_CR78","doi-asserted-by":"publisher","first-page":"e11170","DOI":"10.15252\/emmm.201911170","volume":"11","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist S, Insel PS, Stomrud E, et al. Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer\u2019s disease. EMBO Mol Med. 2019;11(12):e11170.","journal-title":"EMBO Mol Med"},{"issue":"8","key":"2061_CR79","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia J, Ning Y, Chen M, et al. Biomarker Changes during 20 Years Preceding Alzheimer\u2019s Disease. N Engl J Med. 2024;390(8):712\u201322.","journal-title":"N Engl J Med"},{"issue":"3","key":"2061_CR80","doi-asserted-by":"publisher","first-page":"e14528","DOI":"10.1002\/alz.14528","volume":"21","author":"A Leuzy","year":"2025","unstructured":"Leuzy A, Bollack A, Pellegrino D, et al. Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer\u2019s disease. Alzheimers Dement. 2025;21(3):e14528.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"2061_CR81","doi-asserted-by":"publisher","first-page":"e70173","DOI":"10.1002\/alz.70173","volume":"21","author":"DJ Figdore","year":"2025","unstructured":"Figdore DJ, Schuder BJ, Ashrafzadeh-Kian S, Gronquist T, Bornhorst JA, Algeciras-Schimnich A. Differences in Alzheimer\u2019s disease blood biomarker stability: Implications for the use of tau\/amyloid ratios. Alzheimers Dement. 2025;21(4):e70173.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"2061_CR82","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"NJ Ashton","year":"2024","unstructured":"Ashton NJ, Brum WS, Di Molfetta G, et al. Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology. JAMA Neurol. 2024;81(3):255\u201363.","journal-title":"JAMA Neurol"},{"key":"2061_CR83","doi-asserted-by":"crossref","unstructured":"Doecke JD, Chenna A, Lo M et al. Comparing plasma A\u03b242\/40 and pTau217 to predict Amyloid-\u03b2 status across the Alzheimer\u2019s disease continuum. Alzheimer\u2019s Dement. 2024;20(Suppl. 2):e091746.","DOI":"10.1002\/alz.091746"},{"issue":"1","key":"2061_CR84","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen CE, Verberk I, Thijssen EH, et al. Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 2022;21(1):66\u201377.","journal-title":"Lancet Neurol"},{"issue":"12","key":"2061_CR85","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","volume":"28","author":"NJ Ashton","year":"2022","unstructured":"Ashton NJ, Janelidze S, Mattsson-Carlgren N, et al. Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring. Nat Med. 2022;28(12):2555\u201362.","journal-title":"Nat Med"},{"issue":"1","key":"2061_CR86","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13195-021-00942-0","volume":"14","author":"AL Benedet","year":"2022","unstructured":"Benedet AL, Brum WS, Hansson O, et al. The accuracy and robustness of plasma biomarker models for amyloid PET positivity. Alzheimers Res Ther. 2022;14(1):26.","journal-title":"Alzheimers Res Ther"},{"key":"2061_CR87","doi-asserted-by":"publisher","first-page":"102468","DOI":"10.1016\/j.arr.2024.102468","volume":"101","author":"J Li","year":"2024","unstructured":"Li J, Liu Y, Yin C, Zeng Y, Mei Y. Structural and functional remodeling of neural networks in \u03b2-amyloid driven hippocampal hyperactivity. Ageing Res Rev. 2024;101:102468.","journal-title":"Ageing Res Rev"},{"issue":"1","key":"2061_CR88","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1212\/WNL.0000000000004059","volume":"89","author":"RF Buckley","year":"2017","unstructured":"Buckley RF, Schultz AP, Hedden T, et al. Functional network integrity presages cognitive decline in preclinical Alzheimer disease. Neurology. 2017;89(1):29\u201337.","journal-title":"Neurology"},{"issue":"3","key":"2061_CR89","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ana.21904","volume":"67","author":"DM Rentz","year":"2010","unstructured":"Rentz DM, Locascio JJ, Becker JA, et al. Cognition, reserve, and amyloid deposition in normal aging. Ann Neurol. 2010;67(3):353\u201364.","journal-title":"Ann Neurol"},{"issue":"9","key":"2061_CR90","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.jalz.2018.07.219","volume":"16","author":"Y Stern","year":"2020","unstructured":"Stern Y, Arenaza-Urquijo EM, Bartr\u00e9s-Faz D, et al. Whitepaper: Defining and investigating cognitive reserve, brain reserve, and brain maintenance. Alzheimers Dement. 2020;16(9):1305\u201311.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"2061_CR91","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","volume":"76","author":"BJ Hanseeuw","year":"2019","unstructured":"Hanseeuw BJ, Betensky RA, Jacobs H, et al. Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study. JAMA Neurol. 2019;76(8):915\u201324.","journal-title":"JAMA Neurol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02061-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02061-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T02:01:52Z","timestamp":1780970512000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02061-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2061"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02061-0","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}